EN
Contact
TeamExpertise
NewsRankings & AwardsPublications & Presentations
About usCareerContact
de|fr|it|en
DEFRIT
Contact
TeamExpertise
NewsRankings & AwardsPublications & Presentations
About usCareerContact
de|fr|it|en
DEFRIT
de|fr|it|en
Basel Bern Binningen China Desk Geneva Gstaad Japan Desk Lausanne Lugano Sion ZurichBasel Bern Binningen China Desk Geneva Gstaad Japan Desk Lausanne Lugano Sion Zurich
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publications & Presentations
  • About us
  • Career
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publications & Presentations
  • About us
  • Career
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Marco Sibold
  • Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.August 27, 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsMarch 11, 2026
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsMay 15, 2025
  • Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.April 4, 2025
  • Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGDeal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGMarch 13, 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaDecember 3, 2024
  • Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGDeal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGJune 28, 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGMay 27, 2024
  • Deal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOSTDeal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOSTMay 22, 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.August 23, 2023
  • Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGDeal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGAugust 9, 2023
  • Deal Ticker: Kellerhals Carrard advised on sale of Franz Carl WeberDeal Ticker: Kellerhals Carrard advised on sale of Franz Carl WeberJuly 5, 2023